11,153 Shares in UiPath Inc. (NYSE:PATH) Purchased by Qsemble Capital Management LP

Qsemble Capital Management LP acquired a new position in UiPath Inc. (NYSE:PATHFree Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,153 shares of the healthcare company’s stock, valued at approximately $253,000.

Several other institutional investors have also bought and sold shares of PATH. Mark Sheptoff Financial Planning LLC bought a new stake in UiPath in the fourth quarter worth about $25,000. HighMark Wealth Management LLC acquired a new stake in UiPath during the 4th quarter worth about $27,000. ORG Partners LLC raised its holdings in UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after buying an additional 1,112 shares during the period. Cypress Capital Management LLC WY acquired a new stake in UiPath during the 4th quarter worth about $29,000. Finally, GAMMA Investing LLC acquired a new stake in UiPath during the 4th quarter worth about $36,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on PATH shares. TD Cowen restated a “hold” rating and set a $17.00 price objective (down previously from $28.00) on shares of UiPath in a report on Thursday, May 30th. Mizuho cut their price objective on UiPath from $25.00 to $14.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. DA Davidson cut their price objective on UiPath from $24.00 to $13.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. Truist Financial reissued a “hold” rating and issued a $14.00 price target (down from $32.00) on shares of UiPath in a research report on Thursday, May 30th. Finally, KeyCorp reissued a “sector weight” rating on shares of UiPath in a research report on Thursday, May 30th. Sixteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $18.06.

Check Out Our Latest Research Report on UiPath

Insider Activity

In related news, CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the transaction, the chief financial officer now directly owns 946,848 shares of the company’s stock, valued at $18,738,121.92. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 22.37% of the stock is owned by company insiders.

UiPath Stock Up 1.8 %

PATH stock traded up $0.23 during midday trading on Tuesday, hitting $12.70. 7,994,287 shares of the company traded hands, compared to its average volume of 9,983,857. UiPath Inc. has a twelve month low of $11.07 and a twelve month high of $27.87. The business has a 50 day simple moving average of $14.69 and a 200-day simple moving average of $19.76. The stock has a market capitalization of $7.27 billion, a price-to-earnings ratio of -77.97 and a beta of 0.86.

UiPath (NYSE:PATHGet Free Report) last announced its quarterly earnings results on Wednesday, May 29th. The healthcare company reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03). UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The company had revenue of $335.11 million for the quarter, compared to the consensus estimate of $332.84 million. Equities research analysts forecast that UiPath Inc. will post -0.21 EPS for the current year.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHFree Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.